Multiple Sclerosis Clinical Trial
Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis
Summary
This study is an extension to the study AC-058B201 and will investigate the long-term safety, tolerability and efficacy of ponesimod in patients with relapsing-remitting multiple sclerosis.
Eligibility Criteria
Inclusion Criteria:
Patients who completed study treatment at their regular Week 24 (End of treatment) visit within the core study AC-058B201.
Signed informed consent for participating in the extension study.
Exclusion Criteria:
1. Any clinically relevant medical or surgical condition, which, in the opinion of the investigator, would put the patient at risk by participating in the extension study.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Phoenix Arizona, , United States
Scottsdale Arizona, , United States
Palo Alto California, , United States
Sacramento California, , United States
Venice Florida, , United States
Indianapolis Indiana, , United States
Kansas City Kansas, , United States
Lenexa Kansas, , United States
Latham New York, , United States
Schenectady New York, , United States
Stony Brook New York, , United States
Raleigh North Carolina, , United States
Cincinnati Ohio, , United States
Columbus Ohio, , United States
Burlington Vermont, , United States
Kirkland Washington, , United States
Vienna , , Austria
Sofia , , Bulgaria
Ottawa Ontario, , Canada
Brno , , Czechia
Jihlava , , Czechia
Olomouc , , Czechia
Ostrava-Poruba , , Czechia
Praha 2 , , Czechia
Teplice , , Czechia
Helsinki , , Finland
Hyvinkää , , Finland
Tampere , , Finland
Turku , , Finland
Montpellier Cedex 5 , , France
Berlin , , Germany
Essen , , Germany
Ulm , , Germany
Budapest , , Hungary
Esztergom , , Hungary
Győr , , Hungary
Miskolc , , Hungary
Tel-Hashomer , , Israel
Zerifin , , Israel
Breda , , Netherlands
Katowice , , Poland
Poznan , , Poland
Warszawa , , Poland
Wroclaw , , Poland
Cluj-Napoca , , Romania
Timisoara , , Romania
Kazan , , Russian Federation
Moscow , , Russian Federation
Nizhniy Novgorod , , Russian Federation
Pyatigorsk , , Russian Federation
Saint Petersburg , , Russian Federation
Samara , , Russian Federation
Saratov , , Russian Federation
St. Petersburg , , Russian Federation
UFA , , Russian Federation
Belgrade , , Serbia
Kragujevac , , Serbia
Nis , , Serbia
Majadahonda , , Spain
Malaga , , Spain
Sevilla , , Spain
Göteborg , , Sweden
Stockholm , , Sweden
Umeå , , Sweden
Lugano , , Switzerland
Chernihiv , , Ukraine
Dnipropetrovsk , , Ukraine
Kyiv , , Ukraine
Odesa , , Ukraine
Bristol , , United Kingdom
London , , United Kingdom
Plymouth , , United Kingdom
How clear is this clinincal trial information?